Latest Lazard Stories
LONDON, May 8, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the closing of its previously announced initial public offering of 3,500,000 American Depository Shares (ADSs) at a price to the public of $8.90 per share. The Company has granted the underwriters an option to...
LONDON, May 1, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the pricing of its initial public offering of 3,500,000 American Depository Shares ("ADSs") on the NASDAQ Global Market at a price of $8.90 per ADS. GW has also granted the Underwriters a 30-day option to...
MASON, Ohio, April 2, 2013 /PRNewswire/ -- AssureRx Health, Inc. today announced the appointment of Stephen A. Stamp as Senior Vice President & CFO and Jeffrey P. Bush as Vice President, Payer Markets and Reimbursement to its leadership team. The management appointments coincide with increasing demand for GeneSight pharmacogenomic testing services, which support healthcare providers in medication selection and the management of side effects for patients with neuropsychiatric and...
PORTON DOWN, England, March 19, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (AIM: GWP, "GW" or the "Company"), the biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform, announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission (the "SEC") for an initial public offering of American Depositary Shares ("ADSs") on the NASDAQ Global Market. GW...
RADNOR, Pa., Feb. 20, 2013 /PRNewswire/ -- Element Partners, a leading energy, industrial, and environmental technology private equity firm, announced today the promotions of Sam Gabbita to Managing Director and Charles A. Silio and Nitin Gupta to Principal. (Logo: http://photos.prnewswire.com/prnh/20120423/PH91836LOGO ) David Lincoln, Managing Partner of Element, said, "We are pleased to recognize Sam's, Charlie's and Nitin's contributions with these promotions. Over the past...
AUSTIN, Texas, Feb. 19, 2013 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company focused on gynecologic cancers and vascular medicine, has been invited to participate in Lazard Capital Market's 5th Annual Medical Technology Snowbird Conference. The conference is being held at the Cliff Lodge Snowbird Ski & Summer Resort in Snowbird, Utah from February 27 - March 1, 2013. Vermillion's Interim CEO Bruce A. Huebner is scheduled to participate in...
UNION CITY, Calif., Feb. 15, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, Chief Operations Officer, will participate in the Lazard Capital Markets 5(th) Annual Medical Technology Snowbird Conference. The event is being held from February 27 - March 1, 2013 at The Cliff Hotel, Snowbird Ski and Summer Resort in Snowbird, Utah. The conference format consists of a full day...
GREENWICH, Conn., Nov. 26, 2012 /PRNewswire/ -- Littlejohn & Co., LLC, a private investment firm based in Greenwich, CT, announced today that it has signed a definitive agreement to sell its portfolio company, Synchronous Aerospace Group, to Precision Castparts Corp. (NYSE: PCP). Headquartered in Santa Ana, CA, Synchronous is a leading supplier of complex assemblies and precision components that serve mission-critical functions on aircraft in the commercial aerospace and...
CASTLE ROCK, Colo., Nov. 13, 2012 /PRNewswire/ -- AspenBio Pharma, Inc. (Nasdaq: APPY), an in vitro diagnostic company, today announced that it will present at the 9(th) Annual Lazard Capital Markets Healthcare Conference, held November 13-14, 2012, at the Pierre Hotel in New York City. Steve Lundy, President and CEO of AspenBio, will provide an overview of the Company's business during his live presentation and will be available to participate in one-on-one meetings with...
CRANBURY, N.J., Nov. 12, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the Lazard Capital Markets 9(th) Annual Healthcare Conference on Tuesday, November 13, 2012, at 10:30 a.m. Eastern Time. The conference will be held at The Pierre Hotel, New York City. Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs. About Palatin...
